Request Demo
Last update 25 Oct 2025
PanCyte
Last update 25 Oct 2025
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms- |
Target |
Action agonists |
Mechanism Mas receptor agonists(Proto-oncogene Mas agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Structure/Sequence
Sequence Code 525039683
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Marfan Syndrome | Discovery | United States | 06 Feb 2014 | |
| Muscular Dystrophies | Discovery | United States | 06 Feb 2014 | |
| Peripheral Vascular Diseases | Discovery | United States | 05 Mar 2013 | |
| Stroke | Discovery | United States | 05 Mar 2013 | |
| Diabetes Mellitus | Discovery | United States | 30 Nov 2012 | |
| Perioperative ischaemia | Discovery | United States | 30 Nov 2012 | |
| Lung Diseases | Discovery | United States | 31 Oct 2011 | |
| Anemia | Discovery | United States | 12 Oct 2010 | |
| Neutropenia | Discovery | United States | 12 Oct 2010 | |
| Thrombocytopenia | Discovery | United States | 12 Oct 2010 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free